Home › Entities › type_of_chemical_entity › oritavancin

oritavancin

pharmaceutical drug
ChemicalSubstance type_of_chemical_entity Q7102878
Press Enter · cited answer in seconds

oritavancin

Summary

oritavancin is a type of chemical entity[1]. oritavancin ranks in the top 6% of type_of_chemical_entity entities by monthly Wikipedia readership (34 views/month).[2]

Key Facts

  • oritavancin's instance of is recorded as type of chemical entity[3].
  • oritavancin's CAS Registry Number is recorded as 171099-57-3[4].
  • oritavancin's canonical SMILES is recorded as CC1C(C(CC(O1)OC2C3C(=O)NC(C4=CC(=CC(=C4C5=C(C=CC(=C5)C(C(=O)N3)NC(=O)C6C7=CC(=C(C(=C7)OC8=C(C=C(C=C8)C(C(C(=O)NC(C(=O)N6)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)OC9C(C(C(C(O9)CO)O)O)OC1CC(C(C(O1)C)O)(C)NCC1=CC=C(C=C1)C1=CC=C(C=C1)Cl)OC1=C(C=C2C=C1)Cl)O)O)O)C(=O)O)(C)N)O[5].
  • oritavancin's InChI is recorded as InChI=1S/C86H97Cl3N10O26/c1-35(2)22-51(92-7)77(110)98-67-69(105)42-15-20-55(49(88)24-42)120-57-26-44-27-58(73(57)125-84-74(71(107)70(106)59(34-100)122-84)124-62-32-86(6,76(109)37(4)119-62)93-33-38-8-10-39(11-9-38)40-12-17-45(87)18-13-40)121-56-21-16-43(25-50(56)89)72(123-61-31-85(5,91)75(108)36(3)118-61)68-82(115)97-66(83(116)117)48-28-46(101)29-54(103)63(48)47-23-41(14-19-53(47)102)64(79(112)99-68)96-80(113)65(44)95-78(111)52(30-60(90)104)94-81(67)114/h8-21,23-29,35-37,51-52,59,61-62,64-72,74-76,84,92-93,100-103,105-109H,22,30-34,91H2,1-7H3,(H2,90,104)(H,94,114)(H,95,111)(H,96,113)(H,97,115)(H,98,110)(H,99,112)(H,116,117)/t36-,37-,51+,52-,59+,61-,62-,64+,65+,66-,67+,68-,69+,70+,71-,72+,74+,75-,76-,84-,85-,86-/m0/s1[6].
  • oritavancin's InChIKey is recorded as VHFGEBVPHAGQPI-LXKZPTCJSA-N[7].
  • oritavancin's ATC code is recorded as J01XA05[8].
  • oritavancin's chemical formula is recorded as C₈₆H₉₇Cl₃N₁₀O₂₆[9].
  • oritavancin's subclass of is recorded as lipoglycopeptides[10].
  • oritavancin's has use is recorded as medication[11].
  • oritavancin's MeSH descriptor ID is recorded as C100708[12].
  • oritavancin's ChEMBL ID is recorded as CHEMBL1688530[13].
  • oritavancin's Guide to Pharmacology Ligand ID is recorded as 10877[14].
  • oritavancin's Freebase ID is recorded as /m/02q7dw8[15].
  • oritavancin's UNII is recorded as PUG62FRZ2E[16].
  • oritavancin's ChemSpider ID is recorded as 17286443[17].
  • oritavancin's PubChem CID is recorded as 16136912[18].
  • oritavancin's PubChem CID is recorded as 101991076[19].
  • oritavancin's KEGG ID is recorded as C12034[20].
  • oritavancin's ChEBI ID is recorded as 82699[21].
  • oritavancin's DrugBank ID is recorded as DB04911[22].
  • oritavancin's isomeric SMILES is recorded as CNC@HC(=O)N[C@@H]1C@HC2=CC(Cl)=C(OC3=C(O[C@@H]4OC@HC@@HC@H[C@H]4O[C@H]5CC@(NCC6=CC=C(C=C6)C7=CC=C(Cl)C=C7)C@@HC@HO5)C8=CC(=C3)C@@HC(=O)N[C@@H]9C%10=CC=C(O)C(=C%10)C%11=C(C=C(O)C=C%11O)C@HC(O)=O)C=C2C@HC(=O)N[C@@H]1C@HC2=CC(Cl)=C(OC3=C(O[C@@H]4OC@HC@@HC@H[C@H]4O[C@H]5CC@(NCC6=CC=C(C=C6)C7=CC=C(Cl)C=C7)C@@HC@HO5">[23].
  • oritavancin's mass is recorded as {'unit': 'Q483261', 'amount': '+1790.564106'}[24].
  • oritavancin's NDF-RT ID is recorded as N0000191085[25].
  • oritavancin's medical condition treated is recorded as cellulitis[26].
  • oritavancin's subject has role is recorded as protein synthesis inhibitor[27].

Why It Matters

oritavancin ranks in the top 6% of type_of_chemical_entity entities by monthly Wikipedia readership (34 views/month).[2] oritavancin has Wikipedia articles in 11 language editions, a strong signal of global cultural recognition.[28] oritavancin is known by 3 alternative names across languages and contexts.[29]

References

Programmatic citations — every numbered marker resolves to a verifiable graph row below.

Direct Wikidata claims

  1. [3] ↑ . wikidata.org.
  2. [4] ↑ . DrugBank. Retrieved . commonchemistry.cas.org. Provenance: wikidata.org.
  3. [5] ↑ . PubChem. Retrieved . wikidata.org.
  4. [6] ↑ . wikidata.org.
  5. [7] ↑ . PubChem. Retrieved . wikidata.org.
  6. [8] ↑ . DrugBank. wikidata.org.
  7. [9] ↑ . PubChem. Retrieved . wikidata.org.
  8. [10] ↑ . NDF-RT. Retrieved . wikidata.org.
  9. [11] ↑ . DrugBank. wikidata.org.
  10. [12] ↑ . Medical Subject Headings. Retrieved . wikidata.org.
  11. [13] ↑ . ChEMBL. Retrieved . wikidata.org.
  12. [14] ↑ . IUPHAR/BPS Guide to PHARMACOLOGY. Retrieved . wikidata.org.
  13. [15] ↑ . wikidata.org.
  14. [16] ↑ . DrugBank. Retrieved . wikidata.org.
  15. [17] ↑ . Q2311683. Retrieved . wikidata.org.
  16. [18] ↑ . PubChem. Retrieved . wikidata.org.
  17. [19] ↑ . wikidata.org.
  18. [20] ↑ . ChEMBL. Retrieved . wikidata.org.
  19. [21] ↑ . ChEMBL. Retrieved . wikidata.org.
  20. [22] ↑ . wikidata.org.
  21. [23] ↑ . Global Substance Registration System. Retrieved . wikidata.org.
  22. [24] ↑ . PubChem. Retrieved . wikidata.org.
  23. [25] ↑ . NDF-RT. Retrieved . wikidata.org.
  24. [26] ↑ . Drug Indications Extracted from FAERS. Retrieved . wikidata.org.
  25. [27] ↑ . NDF-RT. Retrieved . wikidata.org.

Class ancestry

  1. [1] ↑ . Wikidata. wikidata.org.

Aggregate / graph-position facts

  1. [2] ↑ . Wikimedia Foundation. dumps.wikimedia.org.
  2. [28] ↑ . Wikidata sitelinks. wikidata.org.
  3. [29] ↑ . Wikidata aliases. wikidata.org.

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA 4ort.xyz Knowledge Graph. (2026). oritavancin. Retrieved May 3, 2026, from https://4ort.xyz/entity/oritavancin
MLA “oritavancin.” 4ort.xyz Knowledge Graph, 4ort.xyz, 3 May. 2026, https://4ort.xyz/entity/oritavancin.
BibTeX @misc{4ortxyz_oritavancin_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{oritavancin}}, year = {2026}, url = {https://4ort.xyz/entity/oritavancin}, note = {Accessed: 2026-05-03}}
LLM prompt According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): oritavancin — https://4ort.xyz/entity/oritavancin (retrieved 2026-05-03)

Canonical URL: https://4ort.xyz/entity/oritavancin · Last refreshed: